1065832

APHROZONE USA, INC. — FEI 3012056155

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 17, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Los Angeles, CA (United States)

Citations

IDCFRDescription
433621 CFR 211.150Written distribution procedure